Global Stem Cells Market with Focus on Clinical Therapies, 2020-2030 – Presents a Detailed Clinical Trial Analysis on More Than 540 Completed, Ongoing…

April 23, 2020 medical

Dublin, April 22, 2020 (GLOBE NEWSWIRE) -- The "Global Stem Cells Market: Focus on Clinical Therapies, 2020 - 2030" report has been added to ResearchAndMarkets.com's offering.

Stem cell therapies are viable alternatives to conventional treatments with substantial therapeutic potential; market opportunities are huge, as multiple product candidates are expected to be approved over the coming decade

This report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

One of the key objectives of the report was to estimate the existing market size and identify the future opportunity for stem cell therapies over the next decade. The research, analyses and insights presented in this report are based on revenue generation trends based on the sales of approved stem cell therapies.

The report also features the likely distribution of the current and forecasted opportunity within stem cell therapies market across:

According to the WHO, in 2020, nearly 75% of fatalities that are estimated to be reported across the globe, are likely to be caused due to diseases, such as chronic stroke disease, diabetes, cancer, heart disease, and certain mental health conditions. In addition, as per a report published by the Center for Managing Chronic Disease, University of Michigan, more than 50% of the global population was estimated to be living with some form of chronic illness.

The rising prevalence of these clinical conditions has resulted in dire need for the identification of effective therapeutic options. Despite advances in healthcare, there is an evident lack of permanent treatment solutions for many aforementioned diseases. Majority of the currently available treatment options focus on palliative care and are incapable of addressing the root cause of disease, therefore, are unable to improve quality of life of patients.

Since the first bone marrow transplant in 1950s, these regenerative cellular therapies have garnered significant attention within the biopharmaceutical industry. Over the years, advances in the field of cell biology and regenerative medicine have led to the development of a number of stem cell therapies, which are believed to possess the potential to address several unmet needs related to the treatment of a wide range of disease conditions. Stem cell-based treatments are known for their ability to replace damaged cells and tissues, thereby, curing affiliated disease symptoms.

In fact, such interventions have also been shown to enable cell regeneration, restoring normal functioning capabilities in affected organs. Till date, nearly 25 stem cell-based therapies have been approved; popular examples include EYE-01M (2019), Alofisel (2018), MACI (2016), Stempeucel (2016) and Strimvelis (2016). Further, several such therapies are presently being evaluated across 540 active clinical trials worldwide. This emerging field of research has received significant capital investments from several big pharma companies and venture capital funds / investors.

Despite the associated optimism, the growth of this market is stunted by a number of development and manufacturing related challenges, primarily revolving around the limited availability of the required expertise and infrastructure to produce such products. However, the availability of innovative technology platforms, large target patient population, encouraging clinical trial results, and extensive government support, the stem cell therapies market is poised to grow in the long-term.

In addition to other elements, the study includes:

To account for the uncertainties associated with the manufacturing of stem cell therapies and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market's evolution.

The opinions and insights presented in the report were influenced by discussions held with senior stakeholders in the industry.

The report features detailed transcripts of interviews held with the following industry stakeholders:

Key Topics Covered

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION 3.1. Chapter Overview3.2. Overview of Stem Cell Therapies3.3. Regulatory Guidelines for Stem Cell Therapies3.4. Prevalent Trends Related to Stem Cell Therapies3.5. Growth Drivers and Roadblocks

4. MARKET LANDSCAPE4.1. Chapter Overview4.2. Stem Cell Therapies: Marketed and Development Pipeline4.3. Stem Cell Therapies: Additional Information4.4. Stem Cell Therapies: List of Technology Platforms4.5. Stem Cell Therapies: List of Therapy Developers4.6. Heptagon Representation: Analysis by Phase of Development and Key Therapeutic Area4.7. Grid Representation: Analysis by Phase of Development, Source of Stem Cell and Therapeutic Area4.8. Tree Map Representation: Analysis by Therapeutic Area and Size of the Company4.9. World Map Representation: Analysis of Regional Activity

5. COMPANY PROFILES5.1. Chapter Overview5.2. Anterogen5.2.1. Company Overview5.2.2. Product Portfolio: Clinical-Stage Stem Cell Therapies5.2.3. Recent Developments and Future Outlook5.3. Athersys5.4. CHA Biotech5.5. Cytopeutics5.6. Hope Biosciences5.7. Mesoblast5.8. Pluristem Therapeutics5.9. Takeda Pharmaceutical5.10. TICEBA

6. KEY THERAPEUTIC AREAS6.1. Chapter Overview6.2. Autoimmune / Inflammatory Disorders6.3. Cardiovascular Disorders6.4. Dermatological Disorders6.5. Metabolic Disorders6.6. Oncological Disorders6.7. Neurological Disorders

7. ANSOFF MATRIX EVALUATION7.1. Chapter Overview7.2. Established Therapeutic Areas in Established Regions7.2.1. Competition7.2.2. Growth Opportunities7.3. Established Therapeutic Areas in Emerging Regions7.4. Emerging Therapeutic Areas in Established Regions7.5. Emerging Therapeutic Areas in Emerging Regions

8. ACADEMIC GRANTS ANALYSIS8.1. Chapter Overview8.2. Scope and Methodology8.3. Stem Cell Therapies: Analysis of Grants Awarded by the National Institutes of Health (NIH)8.4. Grant Attractiveness Analysis

9. CLINICAL TRIAL ANALYSIS9.1. Chapter Overview9.2. Scope and Methodology9.3. Stem Cell Therapies: Clinical Trial Analysis

10. STEM CELL MANUFACTURING MARKET LANDSCAPE AND KPIs FOR EVALUATING CONTRACT SERVICES PARTNERS10.1. Chapter Overview10.2. Stem Cell Therapy Manufacturing10.3. Stem Cell Therapy Manufacturing: KPI Analysis10.4. Concluding Remarks

11. STEM CELL THERAPY DEVELOPERS AND CMOs: OPPORTUNITY ASSESSMENT11.1. Chapter Overview11.2. Therapy Developers and CMOs in North America11.3. Therapy Developers and CMOs in Europe11.4. Therapy Developers and CMOs in Asia-Pacific and Rest of the World11.5. Concluding Remarks

12. KEY COMMERCIALIZATION STRATEGIES12.1. Chapter Overview12.2. Successful Drug Launch Strategy: ROOTS Framework12.3. Successful Drug Launch Strategy: Product Differentiation12.4. Commonly Adopted Commercialization Strategies based on Stage of Product Development12.5. Key Approved Stem Cell Therapies: Profiles12.5.1. CARTISTEM12.5.2. HiQCell12.5.3. Prochymal12.5.4. Strimvelis12.6. Key Commercialization Strategies Adopted by Stem Cell Therapy Developers12.6.1. Strategies Adopted before Therapy Approval12.6.2. Strategies Adopted Post Therapy Approval12.7. Opportunities and Challenges with Unapproved Therapies12.8. Concluding Remarks

13. MARKET FORECAST13.1. Chapter Overview13.2. Scope and Limitations13.3. Forecast Methodology and Key Assumptions13.4. Overall Stem Cell Therapies Market, 2020-203013.5. Concluding Remarks

14. CONCLUSION

15. EXECUTIVE INSIGHTS15.1. Chapter Overview15.2. Seraxis15.3. Xcelthera15.4. Kadimastem15.5. Heartseed15.6. University of Rostock15.7. Bio Elpida15.8. Roslin Cell Therapies15.9. University of Minnesota15.10. Waisman Biomanufacturing15.11. YposKesi

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/aajvno

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Go here to read the rest:
Global Stem Cells Market with Focus on Clinical Therapies, 2020-2030 - Presents a Detailed Clinical Trial Analysis on More Than 540 Completed, Ongoing...

Cell Biology

Society for Immunotherapy of Cancer to Host Fundamental Two-Day Workshop Focused on Cytokines in Cancer Immunotherapy – PR Web

April 23, 2020 medical

MILWAUKEE (PRWEB) April 22, 2020

The Society for Immunotherapy of Cancer (SITC) will host a new workshop Oct. 1213, 2020, in New York, which will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches.

The SITC Cytokines in Cancer Immunotherapy Workshop is intended for basic, translational and clinical researchers with a vested interest in the topic of cytokine immunology and the impact of cytokines in cancer immunotherapy. The program is organized by prominent members of the immuno-oncology community, including Susan M. Kaech, PhD, from Salk Institute, Anne OGarra, PhD, from The Francis Crick Institute and Aaron Ring, MD, PhD, from Yale University, the workshop will feature oral presentations by leading experts in the field, including keynotes by Warren J. Leonard, MD, from National Heart, Lung, Blood Institute and Harriett Kluger, MD, from Yale University.

Because cytokines control many aspects of immune cell biology, we see a resurgent interest in developing these agents either alone or in combination with immune checkpoint modulators for anti-cancer therapy, said SITC President Mario Sznol, MD. However, there is a great deal we dont yet know about optimal application of the many different cytokines in the clinic, for example how cytokines interact with each other or with agents such as the PD-1/PD-L1 antagonists. We plan to cover current knowledge in this conference and identify potential areas of research that will lead to rational clinical development. The conference will also provide opportunities for young investigators to present their research and to interact with leading senior investigators in the field.

The workshop will aim to foster renewed exchange and research on the promising topic of cytokines and their interactions in cancer development and therapy, lead to further research and provide a solid scientific foundation for future clinical interventions to modulate anti-tumor immunity with combinations of cytokines and other immunotherapies.

The program will also provide an intimate opportunity for attendees to discuss their work with experts in the field, develop collaborations and learn about novel studies of cytokines. Abstract submissions are being accepted through Sept. 1, 2020, from young investigators working with cytokines in their research, including several oral abstract presentation opportunities. These presentations will be judged on scientific merit, and the top presenter from each category will receive a research funding award. Abstract submitters not selected for oral presentation will have the opportunity to present their research as a poster.

The SITC Cytokines in Cancer Immunotherapy Workshop will take place on Oct. 1213, 2020, at the Millennium Times Square New York hotel. Registration rates, criteria for abstract submissions and program schedule are available on SITC Cancer Immunotherapy CONNECT.

About SITCEstablished in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word cure a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at http://www.sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.

Share article on social media or email:

Here is the original post:
Society for Immunotherapy of Cancer to Host Fundamental Two-Day Workshop Focused on Cytokines in Cancer Immunotherapy - PR Web

Cell Biology

Researchers uncover how cancer cells don their invisibility cloaks – News-Medical.Net

April 23, 2020 medical

Immunotherapy drugs that target a protein called programmed death ligand 1 (PD-L1) on the surface of cancer cells have quickly become a mainstay to treat many forms of cancer, often with dramatic results. But exactly how cancer cells turn on this protein was not completely understood. New research by UT Southwestern Medical Center scientists, published online today in Nature Cancer, lays out key pieces of this mechanism. The findings could offer new targets that may further improve how well current cancer immunotherapies work.

Nearly a decade ago, the Food and Drug Administration approved the first drug in a new class of pharmaceuticals called checkpoint inhibitors. These drugs reverse a cloaking mechanism that many types of cancer cells use to avoid being discovered by the immune system, allowing cancer-fighting immune cells called T cells to attack tumors. Blocking the interaction between one of these cloaking proteins, PD-L1, and its receptor on T cell surfaces forms the basis of several pharmaceuticals currently on the market, including nivolumab, pembrolizumab, and atezolizumab.

Although these drugs have made headway in several types of cancer, notably non-small cell lung cancer (NSCLC) the leading cause of cancer-associated deaths worldwide how cancer cells overexpress PD-L1 to shield themselves from immune system attack has been a mystery.

To help answer that question, Kathryn A. O'Donnell, Ph.D., an associate professor of molecular biology at UT Southwestern, and her colleagues started by looking broadly at which genes might serve as regulators for manufacturing PD-L1 in NSCLC. Using CRISPR, which acts as molecular scissors to remove specific genes, the researchers individually removed 19,000 genes in a human NSCLC cell line. Then, they used a fluorescent PD-L1 antibody to see which cells had more or less PD-L1. This allowed them to identify genes that normally encourage PD-L1 production, or positive regulators, and those that stymie PD-L1 production, or negative regulators.

Surprisingly, they found that a potent inhibitor for the manufacture of PD-L1 is a gene called UROD, which plays a key role in producing heme. This iron-containing chemical is pivotal for carrying oxygen in red blood cells, but is also broadly necessary in other cells for maintaining normal balance, or homeostasis. To confirm these findings, the researchers used other methods to remove heme in NSCLC cells, which also triggered the lung cancer cells to make more PD-L1 protein. When tumors in which UROD was depleted were implanted into healthy mice, they grew significantly faster than those in mice lacking working immune systems. These findings suggest that by activating PD-L1 production, this gene accelerates cancer by suppressing anti-tumor immunity, O'Donnell says.

Further experiments showed that hampering heme production turned on a pathway called the integrated stress response (ISR) that cells broadly use to deal with diverse stress conditions such as low oxygen, toxins, or nutrient starvation. Under these conditions, NSCLC cells used a specialized mechanism, relying on a protein known as eIF5B, to increase PD-L1 production. Just stimulating cells with this single protein could turn up PD-L1 production, the researchers found, even without tampering with heme synthesis.

By examining a database of genes that are over- or underproduced in various cancers, O'Donnell and her team found that the gene encoding eIF5B is frequently overproduced in lung cancers, and that this overproduction in lung cancer patients was a marker for poor prognosis. "Developing new drugs that specifically target this protein, or other proteins involved in making PD-L1, could help improve the success of immunotherapy drugs currently in use," says O'Donnell, also a member of UT Southwestern's Harold C. Simmons Comprehensive Cancer Center.

Investigating the relationship between stress responses and immune evasion in cancer will be an important priority for future work."

Shruthy Suresh, Ph.D., former graduate student researcher and first author of this study

View post:
Researchers uncover how cancer cells don their invisibility cloaks - News-Medical.Net

Cell Biology

A novel method to precisely deliver therapeutics inside the body – Biophotonics.World

April 23, 2020 medical

A team of Penn State researchers are interfacing chemical biology and nanotechnology to develop ultrasound-controlled nanomaterials that can provide on-demand, high precision delivery of proteins into human cells

Image source: Jennifer McCann/Penn State

A new way to deliver therapeutic proteins inside the body uses an acoustically sensitive carrier to encapsulate the proteins and ultrasound to image and guide the package to the exact location required, according to Penn State researchers. Ultrasound then breaks the capsule, allowing the protein to enter the cell.

"When you expose the particle to ultrasound it opens a hole in the cell membrane that lasts for a couple of microseconds," said Scott Medina, assistant professor of biomedical engineering, Penn State. "We can use this temporary opening to deliver antibodies, which are attractive therapeutic molecules in precision medicine that cannot otherwise get inside cells."

These antibodies are emerging therapeutics for cancers, infectious diseases and rheumatoid arthritis, he said.

But getting the protein inside the nanoparticle carrier was not easy, which is why other researchers have had to resort to complicated and often poorly performing methods, such as attaching the cargo to the exterior of nanoparticles, resulting in inefficient protein release and off-target delivery.

The challenge with the new method was that the protein did not want to interact with the interior of the particle, which is made of a fluorous liquid, similar to liquid Teflon. Medina's doctoral student, Janna Sloand, came up with a creative work around -- a fluorous mask. These chemical masks have a counterbalance of polarity and fluorine content that allows the protein to interact with the fluorous liquid medium while maintaining the protein's folded state and bioactivity.

"We had a lot of challenges developing this new method," said Sloand, first author on the paper published recently inACS Nano. "The most difficult was figuring out what kind of chemicals could mask the protein. That was definitely my eureka moment when I saw that it worked."

In future work, the team will explore the use of their ultrasound-programmable material as a platform for image-guided delivery of therapeutic proteins and gene editing tools.

In related therapeutic applications, they are leveraging this technology to deliver antibodies that can alter abnormal signaling pathways in tumor cells to effectively 'turn-off' their malignant traits. In other work they are delivering gene editing tools, like CRISPR constructs, to enable ultrasound-controlled genome engineering of cells in complex 3D tissue microenvironments.

Importantly, these delivery applications can all be performed using ultrasound techniques already employed in hospitals, which they hope will enable the rapid translation of this technology for precision healthcare.

Source: Penn State

Related journal article:http://dx.doi.org/10.1021/acsnano.9b08745

Biochemistry

Biochemistry Analyzers Market Products Report 2020-2026 by Industry Trends and Competition Analysis, Forecast to 2026 – Cole of Duty

April 23, 2020 medical

Biochemistry Analyzers:

This report studies the Biochemistry Analyzers Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Biochemistry Analyzers Market analysis segmented by companies, region, type and applications in the report.

Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-and-southeast-asia-biochemistry-analyzers-industry-2018-market-research-report

Biochemistry Analyzers Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Biochemistry Analyzers Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Regions, regional analysis covers

Research objectives:

Inquire More about This Report @ https://www.reportsandmarkets.com/enquiry/global-and-southeast-asia-biochemistry-analyzers-industry-2018-market-research-report

The Biochemistry Analyzers Market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Table of Contents: Biochemistry Analyzers Market

Key questions answered in this report

Get Complete Report @ https://www.reportsandmarkets.com/checkout?currency=one_user-USD&report_id=2651725

About Us:

ReportsAndMarkets.com allocates the globally available market research and many company reports from reputed market research companies that are a pioneer in their respective domains. We are completely an autonomous group and serves our clients by offering the trustworthy available research stuff, as we know this is an essential aspect of Market Research.

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

View original post here:
Biochemistry Analyzers Market Products Report 2020-2026 by Industry Trends and Competition Analysis, Forecast to 2026 - Cole of Duty

Biochemistry

Global Biochemistry Analysers Market leading key players with impact of covid -19 | HORIBA, Siemens Healthcare, Abbott and Thermo Fisher Scientific -…

April 23, 2020 medical

The research report explores major market consultation ofGlobalBiochemistry AnalysersMarketafter performing accomplished, intellectual and comprehensive analysis. The report helps key vendors, Biochemistry Analysers manufacturers and end-users of the Biochemistry Analysers market to gain better insights, assets and perspectives. Major topographical zones covered in the Biochemistry Analysers report are the Middle East and Africa, North America, Latin America, Europe, and Asia-Pacific.

Thus topping up conflicting facets of Biochemistry Analysers industry including industrial outlines, schedules, and apparent approaches. It also clears crucial criterions such as company contact information including email address, website addresses, and phone numbers, Biochemistry Analysers industry group, classification, order to supply ratio, sales allowance, cost/price of the product, and key vendors.

Recent vendors that are new to Biochemistry Analysers business find it troublesome to compete with existing market opponent located worldwide. The Biochemistry Analysers market study will be useful for Medical Devices industry executives, product managers, sales, analysts, and consultants. A broad description of plans and policies, product distribution, economic and behavioral policies is also established. Professionals and experts conduct primary and secondary research to gather necessary statistics of the industry by considering SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis. It gives a close idea about raw materials used, innovative technologies, scope and changing arrangements of the marketing channels.

Global Biochemistry Analysers market research report is primarily discriminated as competitors, major geographical regions, product types and applications.

Major dominant players of global Biochemistry Analysers market are

Abbott, Xylem Analytics, Agappe Diagnostics, Siemens Healthcare, HORIBA, RMS, Labindia Instruments, MicroLab Instruments and Thermo Fisher Scientific

Based on Product TypesBiochemistry Analysers marketisolated into

Based on Applications Biochemistry Analysers marketisolated into

On the basis of the geographical study, the Biochemistry Analysers market control over North America, Asia-Pacific, the Middle East and Africa, Latin America, Europe. Considering the global scenario of the Biochemistry Analysers market, North America region is holding to be the biggest market for Biochemistry Analysers. Moreover, the European market is also growing and the second largest market for Biochemistry Analysers. Rest of the World is likely to have a limited but steady expansion in the Biochemistry Analysers business.

Fill the Inquiry Form to Try Sample Copy of Reporthttps://market.biz/report/global-biochemistry-analysers-market-qy/426862/#inquiry

Crystal insights of Biochemistry Analysers market along with market opportunities, threats, and growth is covered in this research report. It inspect present divisions to predict evolving ones and gives detailed segmentation of the industry on the basis of product types, Biochemistry Analysers applications, and major geographical regions. In-depth study of the market share and contribution is also mentioned in the report.

It highlights Biochemistry Analysers leading marketing players along with their different strategies and approaches used. This report study gives information about local, regional and international markets and developing segments. Market dynamics that keeps on changing over time and in-depth scrutiny of the market sources are also cited.

It conducts a deeper study of past and current Biochemistry Analysers market tendencies to predict future market growth in terms of volume and value. It also computes core parameters such as industrial advancements and growth and delivers fundamental market figures in the form of tables, pie charts, graphs and flows charts.

Major applications of Biochemistry Analysers imarketare also determined based on performance and accomplishments. Shrine to industries unsettled to improve their ledge is also discussed.

Usually asked questionson market research report:

1.What are current global Biochemistry Analysers market tendencies, obstructions, and challenges faced by the key competitors of Biochemistry Analysers market?

2.What are major outcomes and consequences of the five strengths study of Biochemistry Analysers industry?

3.What willbe the Biochemistry Analysers market capacity and growth estimation forecast up to 2026?

4.Who are the major players in the global Biochemistry Analysers market and what ways they follow to increase overall revenue?

5.What are the durabilities and defects of the Biochemistry Analysers industry?

At the end, the Global Biochemistry Analysers Market report delivers high-level information both in terms of quality and quantity. It also gives a summary of the Biochemistry Analysers vendor, dealer, contributors to the market along with research findings, data source, and appendix.

Get in touch with Us:

420 Lexington Avenue Suite 300

New York City, NY 10170, United States

USA/Canada Tel No:+1-857-2390696

Email:[emailprotected]

Website:https://market.biz/

Go here to read the rest:
Global Biochemistry Analysers Market leading key players with impact of covid -19 | HORIBA, Siemens Healthcare, Abbott and Thermo Fisher Scientific -...

Biochemistry

‘The entire world coming together’: U of T alumni’s website highlights COVID-19 research, recoveries – News@UofT

April 23, 2020 medical

In March, as the number of COVID-19 cases ascended worldwide, University of Toronto alumnaJuliana Leerealized that she had been posting so much negative news about the pandemic on Instagram and Facebook that she herself was becoming anxious and depressed.

Frankly, I didnt realize what I was doing to my own mental health, she says. I started to look for positive news and I realized that theres actually so much out there regarding recovering patient stories and treatment and vaccine news, but the news media doesnt give enough of a spotlight to those.

I thought, Why not create a website that focuses on those specifically?

Along with fellow Trinity College alumnaSophia Shimand current masters studentLeo Zhu Lee, Lee launchedwww.covid19recovery.neton March 18 to promote promising news associated with COVID-19. The site highlights the many vaccines being developed throughout the world and the stories of people who have regained their health after battling the virus. It also aims to educate, by explaining the science associated with the pandemic, and provide levity, with a quarantine playlist, links to music livestreams and suggestions for indoor health and wellness activities.

Lees favourite part of the website is the community section that focuses on the good works of people around the globe fromthe U of T medicine students who are performing domestic tasks for health-care workers to people in Turkey who are leaving food packages outdoors for the needy.

The site garnered thousands of unique visitors from more than 70 countries in its first two weeks. It is now on Instagram and Facebook and offers a weekly newsletter.

Lee is well-suited to explain science to a general audience: She has a bachelors degree in immunology and biochemistry from U of T and now studies infectious diseases as a masters student in clinical medicine at the University of Oxford. (Lees lab work involves studying malaria, while some of her lab colleagues are currently working on COVID-19 vaccines.)

She traces her interest in explaining science to the public to an experience in a second-year organic chemistry class at U of T. She had participated in a chemistry challenge and was selected to present her slides.

It was such an amazing feeling to be able to present something that I know to people that I didnt know, she says. That feeling still carries on, and I think that might have been what powered me to develop this website showing what I know to the general public.

The website has not only helped alleviate some of Lees own anxiety, but it has made her acutely aware of the empathetic global response to the pandemic.

One thing I realized while maintaining this website was that, literally, everyone around the world is moving toward one goal, which is fighting COVID-19, Lee says. I think its such a wonderful thing thats happening because I dont remember ever seeing the entire world coming together to fight for one goal. Seeing all these communities from different countries doing good for others is really heartwarming.

Biochemistry

Biochemistry Analyzers Market Projected to Witness a Double-Digit CAGR During 2020 to 2026 – Surfacing Magazine

April 23, 2020 medical

Biochemistry AnalyzersMarket Report 2020-2026includes a comprehensive analysis of the present Market. The report starts with the basic Biochemistry Analyzers industry overview and then goes into each and every detail.

Biochemistry Analyzers Market Report contains in-depth information on major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. Biochemistry Analyzers also provides data about the company and its operations. This report also provides information on the Pricing Strategy, Brand Strategy, Target Client, Distributors/Traders List offered by the company.

Biochemistry Analyzers Market competition by top manufacturers/players, with Biochemistry Analyzers sales volume, Price (USD/Unit), Revenue (Million USD) and Market Share for each manufacturer/player; the top players including Abbott, Danaher Corporation, F.Hoffman-La Roche Ltd., Siemens AG, Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Meril, Hologic Inc., Beckman Coulter Inc., and Horiba Medical.

Ask for Sample Copy of the Report: @ https://www.coherentmarketinsights.com/insight/request-sample/1873

Important Features that are under offering & key highlights of the report:

1) What all regional segmentation covered? Can the specific country of interest be added?Currently, the research report gives special attention and focus on the following regions:North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Russia, Spain etc), South America (Brazil, Argentina etc) & Middle East & Africa (Saudi Arabia, South Africa etc)** One country of specific interest can be included at no added cost. For inclusion of more regional segment quote may vary.

2) What all companies are currently profiled in the report?The report Contain the Major Key Players currently profiled in this market.** List of companies mentioned may vary in the final report subject to Name Change / Merger etc.

3) Can we add or profiled new company as per our need?Yes, we can add or profile new company as per client need in the report. Final confirmation to be provided by the research team depending upon the difficulty of the survey.** Data availability will be confirmed by research in case of a privately held company. Up to 3 players can be added at no added cost.

4) Can the inclusion of additional Segmentation / Market breakdown is possible?Yes, the inclusion of additional segmentation / Market breakdown is possible to subject to data availability and difficulty of the survey. However, a detailed requirement needs to be shared with our research before giving final confirmation to the client.** Depending upon the requirement the deliverable time and quote will vary.

Get PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1873

Biochemistry Analyzers Market Dynamics in the world mainly, the worldwide 2018-2026 Biochemistry Analyzers Market is analyzed across major global regions. CMI also provides customized specific regional and country-level reports for the following areas:

Region Segmentation:

North America (USA, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, Columbia etc.)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Key questions answered in the report:

1. What will the market growth rate of Biochemistry Analyzers market in 20262. What are the key factors driving the global Biochemistry Analyzers market3. Who are the key manufacturers in Biochemistry Analyzers market space?4. What are the market opportunities, market risk and market overview of the Biochemistry Analyzers market?5. What are sales, revenue, and price analysis by types and applications of Biochemistry Analyzers market?6. What are sales, revenue, and price analysis by regions of Biochemistry Analyzers industry?

Further in the report, the Biochemistry Analyzers market is examined for Sales, Revenue, Price and Gross Margin. These points are analyzed for companies, types, and regions. In continuation with this data, the sale price is for various types, applications and region is also included. The Biochemistry Analyzers industry consumption for major regions is given. Additionally, type wise and application wise figures are also provided in this report.

Ask Query for more details @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1873

In this study, the years considered to estimate the market size of 2018-2026 Biochemistry Analyzers Market are as follows:History Year: 2015-2017Base Year: 2017Estimated Year: 2018Forecast Year 2018 to 2026

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Name: Mr. Raj Shah

Phone: US +12067016702 / UK +4402081334027

Email: sales@coherentmarketinsights.com

Visit our Blog: https://hospitalhealthcareblog.wordpress.com/

View post:
Biochemistry Analyzers Market Projected to Witness a Double-Digit CAGR During 2020 to 2026 - Surfacing Magazine

Biochemistry

Fourteen UB students named SUNY Chancellor’s Award recipients – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter

April 23, 2020 medical

Campus News

By GINA CARBONE

Fourteen UB students have been chosen to receive the 2020 SUNY Chancellors Award for Student Excellence, the highest honor SUNY bestows upon its students.

The annual award recognizes and honors students who have best demonstrated and been recognized for integrating academic excellence with accomplishments in the areas of leadership, athletics, community service, creative and performing arts, campus involvement or career achievement.

Recipients are chosen by a committee of SUNY campus presidents that reviews the accomplishments of nominees and then forwards recommendations to the Chancellors Office for a second review. Finalists are then recommended to the chancellor, who makes the final determination.

This years recipients:

Jonathan Bessette

Jonathan Bessette of Buffalo graduates with a bachelor of science in mechanical engineering and a minor in studio art. Bessette is a University Honors College Scholar and was selected as a Marshall Scholar finalist, a U.S.-U.K. Summer Institute Fulbright Scholar and a U.S. Department of State Critical Language Scholar. Bessette has been involved in humanitarian research, entrepreneurship and outreach. Examples of his work include designing a high-payload and an unmanned aerial vehicle, researching water quality in India, and extensive teaching experience both in the Buffalo Public Schools and abroad.

Fatak G. Borhani

Fatak Borhani of Buffalo graduates with a bachelor of science in aerospace engineering. Borhani has been named one of Tomorrows Technology Leaders: The 20 Twenties by Aviation Week Network. He was presented with an Undergraduate Researcher Award presented on behalf of UBs Department of Mechanical and Aerospace Engineering. The thesis he completed as a University Honors College Advanced Honors Scholar was presented at the Small Satellite Conference in 2019. Borhani has worked in the mechatronics engineering co-op program of NASAs Jet Propulsion Laboratory, assisting on spacecraft that will study Earths climate change.

Liam Christie

Liam Christie of Elma graduates with a bachelor of science in electrical engineering. Christie has been an undergraduate research scholar in the Sensors and Microactuators Learning Lab, focusing on advancing biometric and medical technologies. A Western New York Prosperity Fellow, Christie has focused his entrepreneurial work on making personalized medicine more accessible to all. He has also been active in STEM outreach, including serving as a classroom leader for the Science is Elementary Program.

Summer J. Davis

Summer Davis of Ithaca graduates with a combined bachelor of science degree in occupational science and a masters of science in occupational therapy, as well as a microcredential in interprofessional collaborative practice. Davis is a University Honors College Scholar, Perry Scholar and president of Pi Theta Epsilon, Tau Chapter. She has served as a teaching assistant, peer mentor, graduate assistant for Accessibility Resources and student admissions recruitment specialist for the Office of Admissions. Outside the classroom, Davis interns at the Center for Assistive Technology.

Megan E. Dwyer

Megan Dwyer of Baldwinsville graduates with a bachelor of science in biological sciences. Dwyer, a University Honors College Scholar, has served as a teaching assistant for the Honors Colloquium and an academic assistant for the first-year residential community. She conducted research in the Department of Biotechnical and Clinical Laboratory Sciences, the Department of Biological Sciences and at Roswell Park Comprehensive Cancer Center. Dwyer volunteers with Danceability, a movement program for individuals with special needs.

Katherine M. Eaton

Katherine Eaton of East Amherst graduates with a bachelor of science degree in biological sciences. Eaton is a University Honors College Scholar and member of the Department of Biological Sciences Honors Program. As an Evolutionary Biology Lab teaching assistant, Eaton has taught 60 students. She has done research in biology and geology labs, examining the impact of climate change and overfishing on the evolution of aquatic organisms.

Daniela R. Falcone

Daniela Falcone of West Seneca graduates with a bachelor of science degree in biochemistry and a minor in Italian. Falcone is a University Honors College Scholar, and has been a resident adviser, an orientation team leader and a teaching assistant in cellular biology. She traveled abroad to Panama during spring break 2019 to serve on a medical service trip. Falcone also conducts research in a biochemistry laboratory, contributing to advancements in characterizing kidney cancer.

Dennis C. Fedorishin

Dennis Fedorishin of East Amherst graduates with a bachelor of science in computer science. Fedorishin has been a recipient of the nationally prestigious Barry M. Goldwater Scholarship. His work has contributed to a patent and to peer-reviewed publications. He has participated in numerous poster presentations and received personal project funding. He is currently a software and research engineer at ACV Auctions and a research assistant at UB, working in the field of artificial intelligence research.

Arsh Issany

Arsh Issany of Great Neck graduates with a bachelor of science in biomedical sciences and a bachelor of arts in psychology. Issany has worked as a research assistant in the Department of Nuclear Medicine, as well as in the Maternal and Child Health Lab, where he contributed to publications and grants. He founded the Buffalo chapter of Volunteers Around the World; was vice president of Sub-Board Inc., a multimillion-dollar nonprofit; and has served as the director of student affairs for the undergraduate Student Association.

Lisa R. Marcellus

Lisa Marcellus of Rochester graduates with a bachelor of science in business administration with a concentration in international business, a bachelor of arts in environmental studies and a minor in Spanish. Marcellus is a University Honors College Scholar and a College of Arts and Sciences Deans Scholar. She has been a resident adviser, teaching assistant, event assistant for the UB Distinguished Speakers Series, president of the Buffalo Undergraduate Consulting Group and leadership peer mentor. She helped rebuild houses in Puerto Rico as part of the first SUNY Stands with Puerto Rico initiative.

Kathleen Ohman

Kathleen Ohman of Spencerport graduates with a bachelor of science in biological sciences and a bachelor of arts in psychology, along with a minor in public health. Ohman, a University Honors College Scholar, has received a Presidential Scholarship and Grace W. Capen Award. She has worked as a research assistant in exercise science, psychology and bioacoustics labs, and received the Robert W. Young Award for Undergraduate Research in Acoustics from the Acoustical Society of America. Ohman has also served as music director of the Enchords, a UB a cappella group.

Jillian P. OShaughnessy

Jillian OShaughnessy of Fairport graduates with a bachelor of science in biotechnology and a bachelor of arts in Spanish. OShaughnessy is a University Honors College Scholar. Along with conducting biotechnology research at UB, she co-authored a University of Cambridge Department of Genetics research publication. OShaughnessy is a medical assistant, teaching assistant, triathlon champion, president of UBs Aces Tennis club and a volunteer with Journeys End Refugee Services. She has been accepted into medical school.

Alyssa Reese

Alyssa Reese of Hilton graduates with a bachelor of science in biomedical sciences; a bachelor of arts in the legal studies concentration, Social Sciences Interdisciplinary Program; and a minor in Spanish. A University Honors College Ambassador, Reese has been president of the UB Association of Pre-Medical Students and Mock Trial club, and a member of the Royal Pitches a cappella ensemble, Impulse Dance Force and the UB Love Your Melon Crew. She has been involved in 10 research projects and volunteers with Crisis Text Line, the Alzheimers Association and Newborns in Need.

David Tallents

David Tallents of Fulton graduates with a bachelor of arts in mathematics-economics and political science, with a concentration in international politics and a minor in English. Tallents is a University Honors College Scholar and received a Presidential Scholarship. An AmeriCorps alumnus, Tallents is also a former Presidential Fellow for the Center for the Study of the Presidency and Congress, and has published research on American foreign policy.

See original here:
Fourteen UB students named SUNY Chancellor's Award recipients - UB Now: News and views for UB faculty and staff - University at Buffalo Reporter

Biochemistry

Titanium catalyst enables reactions with the help of green light – Chemie.de

April 23, 2020 medical

Flasks containing the titanium catalyst and the red dye, which are irradiated with green light in the laboratory of the Kekul Institute of Organic Chemistry and Biochemistry.

For the first time, chemists at the University of Bonn and Lehigh University in Bethlehem (USA) have developed a titanium catalyst that makes light usable for selective chemical reactions. It provides a cost-effective and non-toxic alternative to the ruthenium and iridium catalysts used so far, which are based on very expensive and toxic metals. The new catalyst can be used to produce highly selective chemical products that can provide the basis for antiviral drugs or luminescent dyes, for example.

The electrons in chemical molecules are reluctant to lead a single life; they usually occur in pairs. Then they are particularly stable and do not tend to forge new partnerships in the form of new bonds. However, if some of the electrons are brought to a higher energy level with the help of light (photons), things begin to look different when it comes to this "monogamy": In such an excited state, the molecules like to donate or to accept an electron. This creates so-called "radicals", that have electrons, are highly reactive and can be used to form new bonds.

The new catalyst is based on this principle: At its core is titanium, which is connected to a carbon ring in which the electrons are particularly mobile and can be easily excited. Green light is sufficient to use the catalyst for electron transfer to produce reactive organic intermediates that are otherwise not easily obtainable. "In the laboratory, we irradiated a reaction flask containing the titanium catalyst that can be viewed as a red dye with green light," reports Prof. Dr. Andreas Gansuer from the Kekul Institute of Organic Chemistry and Biochemistry at the University of Bonn. "And it worked right away." The mixture generates radicals from organic molecules that initiate many reaction cycles from which a wide variety of chemical products can be produced.

A key factor in reactions with this photo redox catalyst is the wavelength of the light used for irradiation. "Ultraviolet radiation is unsuitable because it is far too energy-rich and would destroy the organic compounds," says Gansuer. Green light from LED lamps is both mild and energy-rich enough to trigger the reaction.

Catalysts are substances that increase the speed of chemical reactions and reduce the activation energy without being consumed themselves. This means that they are available continuously and can trigger reactions that would otherwise not occur in this form. The catalyst can be tailored to the desired products depending on the organic molecule with which the titanium is bonded.

The new titanium catalyst facilitates the reactions of epoxides, a group of chemicals from which epoxy resin are made. These are used as an adhesive or for composites. However, the scientists are not aiming for this mass product, but for the synthesis of much more valuable fine chemicals. "The titanium-based, tailor-made photo redox catalysts can for instance be used to produce building blocks for antiviral drugs or luminescent dyes," says Gansuer. He is confident that these new catalysts provide a cost-effective and more sustainable alternative to the ruthenium and iridium catalysts used so far, which are based on very expensive and toxic metals.

The development is an international collaborative effort by Zhenhua Zhang, Tobias Hilche, Daniel Slak, Niels Rietdijk and Andreas Gansuer from the University of Bonn and Ugochinyere N. Oloyede and Robert A. Flowers II from Lehigh University (USA). While the scientists from the University of Bonn investigated how the desired compounds could best be synthesized with the new catalyst, their colleagues from the USA carried out measurements to prove the reaction pathways. "The luminescence phenomenon really opens up interesting space to consider the design of new sustainable reactions that proceed through free radical intermediates," says Prof. Robert Flowers from the Lehigh University.

'+_msgObj.message+'

You are currently not logged in to my.chemeurope.com .Your changes will in fact be stored however can be lost at all times.

Go here to read the rest:
Titanium catalyst enables reactions with the help of green light - Chemie.de